期刊文献+

靶向于人端粒酶逆转录酶的miR-138增强结肠癌细胞SW480对5-氟尿嘧啶的敏感性 被引量:2

MiR-138 targeting human telomerase revegse transcriptase enhanced the sensitization of colon canc- er cell SW480 to 5-fluorouracil
原文传递
导出
摘要 目的观察miR-138对结肠癌细胞SW480人端粒酶逆转录酶(hTERT)表达的影响,探讨miR-138模拟体mimic沉默hTERT在SW480对5-氟尿嘧啶(5-Fu)化疗药物敏感性中的作用。方法流式细胞仪检测50nmol/L和10nmol/LmiR-138模拟体(mimic)转染SW480后hTERT的表达;5μl异硫氰酸荧光素(FITC)标记的细胞核增殖抗原(Ki-67)抗体染色转染和未转染50nmol/Lmimic的SW480,流式细胞仪检测1mmol/L5-Fu处理和未处理的细胞增殖;碘化丙锭(PI)单染和膜联蛋白V(AnnexinV)-PI双染转染和未转染50nmol/Lmimic的SW480,流式细胞仪检测1mmol/L5-Fu处理和未处理的细胞周期和凋亡状态。结果miR-138mimic在50nmol/L和10nmol/L时,hTERT表达率分别为(30.25±1.34)%和(60.03±2.78)%,而阴性对照组为(87.50±1.63)%;转染miR-138mimic的SW480细胞组与非转染组Ki-67阳性细胞分别为(58.18±2.90)%和(83.45±2.41)%;sub.Go期分别为(27.33±1.70)%和(1.05±0.19)%;凋亡率达(29.50±2.27)%和(5.30±1.74)%;mimic转染组、5-Fu处理组和mimic转染与5-Fu联合组的细胞增殖率分别为(61.00±1.73)%、(57.00±2.03)%和(23.00±1.24)%,sub-G0期细胞分别为(28.12±1.47)%、(34.87±2.01)%和(70.94±3.04)%;凋亡细胞比例分别为(32.15±2.76)%、(40.07±2.58)%和(80.84±3.06)%,差异均有统计学意义(P〈0.05)。结论MiR-138mimic可以抑制SW480中hTERT表达并增强SW480对5-Fu的敏感性。 Objective To observe the effect of miR-138 on the expression of human telomerase re- verse transcriptase (hTERT) in human colon cancer cell SW480 and to evaluate influence of miR-138 mimic on the sensitization of SW480 to 5-fluorouracil (5-Fu). Methods Flow cytometry was used to detect the expression of hTERT in SW48 cells transfected with 50 and 10 nmol/L miR-138 mimic. Both SW480 cells transfected and un-transfected with 50 nmol./L miR-138 mimic were stained by FITC-labeled Ki-67 antibody and assayed by using flow cytometry. The apoptosis of both SW480 cells transfected and un- transfected with 50 nmol/L miR-138 mimic was tested by using PI single dye method and Annexin V-P! ap- optosis assay. Results miR-138 mimic at 50 and 10 nmol/L down-regulated the expression of hTERT at ( 30. 25 ± 1.34) % and ( 60.03 ± 2.78 ) % respectively, and the expression rate of hTERT in the control group was (87. 50 ± 1.63 )%. In SW480 cells transfected or un-transfected with 50 nmol/L of miR-138 mimic, the Ki-67 positive rate was (58.18 ±2. 90)% was (83.45 ±2.41 )%, sub-G0 rate was (27. 33 ± 1.70)% and (1.05 ±0.19)%, and apoptosis rate was (29.50 ±2.27)% and (5.30 ± 1.74)%, respectively. In miR-138 mimic-transfected group, 5-Fu-treated group, and combined treatment group, proliferation rate was (61.00 ± 1.73)% , (57.00 ±2.03)% and (23.00 ± 1.24)% , sub-G0 rate was (28. 12±1.47)%, (34.87 ±2.01)% and (70.94 ±3.04)%, and apoptosis rate was (32.15± 2. 76)% , (40. 07 ±2. 58)% and (80. 84±3.06)% in SW480 cells, respectively. All differences were statistically significant ( P 〈 0. 05 ). Conclusion miR-138 mimic inhibited the expression of hTERT in SW480 cells, and enhanced sensitization of SW480 cells to 5-Fu.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第11期2185-2187,共3页 Chinese Journal of Experimental Surgery
关键词 结肠癌 端粒酶 5-氟尿嘧啶 miR-138 Colon carcinoma Telomerase 5-fluorouracit miR-138
  • 相关文献

参考文献9

  • 1王春雷,张国华,邓心新,顾倬云,郑晓非,王彩云,刘海玲.结直肠癌组织端粒酶活性的表达及临床价值[J].中华实验外科杂志,1999,16(3):281-281. 被引量:2
  • 2郝玉宾,李洪云,彭彦辉,张金梅,楚伟,朱俊真.非核素标记检测端粒酶活性的研究[J].中华实验外科杂志,2000,17(1):88-88. 被引量:2
  • 3Gertler R, Rosenberg R, Strieker D, et al. elomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol, 2004,22 : 1807- 1814.
  • 4Miri-Moghaddam E, Deezagi A, Soheili ZS, et al. Apoptosis and re- duced cell proliferation of HL-60 cell line caused by human telomerase reverse transcriptase inhibition by siRNA. Acta Haematol. 2010,124: 72-78.
  • 5Nakamura M, Masutomi K, Kyo S, et al. Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensi- tizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther,2005,16 : 859-868.
  • 6Mitomo S, Maesawa C, Ogasawara S, et al. Downregulation of miR-138 is associated with overexpression of human telomerasc reverse tran- scriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci ,2008,99:280-286.
  • 7马晋平,陈创奇,赵刚,蔡世荣,何裕隆,詹文华,吴恺明,吴晖,王昭.小干扰RNA抑制人端粒酶逆转录酶基因对胃癌细胞增殖的影响[J].中华实验外科杂志,2010,27(12):1889-1891. 被引量:6
  • 8Bermudez Y, Erasso D, Johnson NC, et al. Telomerase confers resist- ance to easpase-mediated apoptosis. Clin Interv Aging,2006,1:155- 167.
  • 9Carthew RW. Gene regulation by microRNAs. Curr Opin Genet Dev, 2006,16:203-208.

二级参考文献7

  • 1Bodnar AG,Ouellette M,Frolkis M,et al.Extension of life-span by introduction of telomerase into normal human cells.Science,1998,279:349-352.
  • 2Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296:550-553.
  • 3Paul CP,Good PD,Winer I,et al.Effective expression of small interfering RNA in human cells.Nature Biotechno1,2002,20:505-508.
  • 4Qian X,Cheng J,Chen A,et al.Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity.Oncol Rep,2008,19:575-581.
  • 5Aloysius J. Klingelhutz. Telomerase activation and cancer[J] 1997,Journal of Molecular Medicine(1):45~49
  • 6毛立军,郑骏年,李望,陈家存,温儒民,王军起,孙晓青.RNAi人端粒酶逆转录酶基因腺病毒表达载体的构建及对肾癌细胞生长的抑制作用[J].中华实验外科杂志,2008,25(1):77-79. 被引量:5
  • 7徐为,刘俊杰,宋文哲,毛立军,高超,韩东,裴冬生,郑骏年.表达人端粒酶逆转录酶小干扰RNA的增殖腺病毒对肝癌细胞的抑制作用[J].中华实验外科杂志,2008,25(11):1385-1387. 被引量:1

共引文献7

同被引文献28

  • 1Ili CG, Brebi P, Lopez J, et al. Genotyping of human papillomavirus in cervical Intraepithelial neoplasia in a high- risk population [ J ]. J Med Virol, 2011,83 (5) : 833-837.
  • 2Iorio MV, Croce CM. MicroRNAs incancer: small molecules with a hugeimpact [J]. J Clin Oncol,2009,27 (34):5848- 5850.
  • 3Lu j, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers [J]. Nature,2005,435 (7043):834- 838.
  • 4Liu XQ, Jiang L, Wang AX, et al. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines [J]. Cancer Lett, 2009, 286(2) : 271-222.
  • 5Jin Y, Chen D, Robert J, Cabay, et al. Role of microRNA- 138 as a potential tumor suppressor in head and neck squamous cell carcinoma [J]. Int Rev Cell Mol Biol, 2013, 303 : 35-385.
  • 6Mossa B, Mossa S, Marziani R. Adjuvant chemotherapy verSUS radiation Therapy after radical surgery in high-risk positive node stage I B/II A cervical cancer [J]. Eur J Gynaecol On- col, 2010,31 (5) : 545-550.
  • 7Zhao X, Yang L, Wang Y, et al. Down-regulationof miR- 27amightinhibit proliferationanddrug resistance ofgastriccancer ceils [J]. J ExpClin Cancer Res,2011,30:55.
  • 8Liu XQ, Wang C, Chen ZJ, et al. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines[J]. Biochem J, 2011, 440(1): 23-31.
  • 9Scheurer ME, Tortolero - Luna G, Adler - Storthz K. Human pap- illomavirus infection : biology, epidemiology, and prevention [J ]. Int J Gynecol Cancer, 2005, 15(5) : 727 -746.
  • 10Tu YC, Wang HH. HPV knowledge and factors associated with in- tention to use condoms for reducing HPV infection risk among adoles- cent women in taiwan[J]. Women Health, 2015, 55(2): 187 - 202.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部